The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
76267735 7626773 5 F 200912 20160630 20101013 20160927 PER US-ASTRAZENECA-2010SE22945 ASTRAZENECA 703.00 MON F Y 81.60000 KG 20160927 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
76267735 7626773 1 PS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/ 4.5 MCG, TWO INHALATIONS TWICE DAILY 3001092C00 21929
76267735 7626773 2 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/ 4.5 MCG, TWO INHALATIONS TWICE DAILY 3001092C00 21929
76267735 7626773 3 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/ 4.5 MCG, 2 PUFFS TWICE A DAY, 3001195C00 21929
76267735 7626773 4 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/ 4.5 MCG, 2 PUFFS TWICE A DAY, 3001195C00 21929
76267735 7626773 5 C LITHIUM. LITHIUM 1 0 1200 MG QD
76267735 7626773 6 C LITHIUM. LITHIUM 1 0 300 MG BID
76267735 7626773 7 C NAVANE THIOTHIXENE 1 0 4 MG QD
76267735 7626773 8 C RISPERDAL RISPERIDONE 1 0 2 MG QD
76267735 7626773 9 C ZANTAC RANITIDINE HYDROCHLORIDE 1 TWO TIMES A DAY 0
76267735 7626773 10 C CELEXA CITALOPRAM HYDROBROMIDE 1 0 20 MG QD
76267735 7626773 11 C OXYGEN. OXYGEN 1 Nasal 0 1.5 L QD
76267735 7626773 12 C PROAIR HFA ALBUTEROL SULFATE 1 Respiratory (inhalation) 0
76267735 7626773 13 C SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Respiratory (inhalation) 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
76267735 7626773 1 Chronic obstructive pulmonary disease
76267735 7626773 2 Emphysema
76267735 7626773 3 Chronic obstructive pulmonary disease
76267735 7626773 4 Emphysema
76267735 7626773 11 Dyspnoea
76267735 7626773 12 Supplementation therapy

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
76267735 7626773 Chills
76267735 7626773 Circumstance or information capable of leading to medication error
76267735 7626773 Drug dose omission
76267735 7626773 Dyspnoea
76267735 7626773 Fatigue
76267735 7626773 Feeling cold
76267735 7626773 Intentional device misuse
76267735 7626773 Panic reaction
76267735 7626773 Product quality issue

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
76267735 7626773 1 200912 0
76267735 7626773 2 200912 0
76267735 7626773 3 200912 0
76267735 7626773 4 200912 0